Mark Applegate was an executive director of Manufacturing at Vical Incorporated, a biopharmaceutical company focused on DNA vaccine and gene therapy technologies. Applegate earned his undergraduate degree from the University of Delaware before completing his Ph.D. in chemical engineering at MIT, where his fellowship began in 1987. He built a career in biopharmaceutical manufacturing, overseeing the complex processes required to produce gene therapy and nucleic acid therapeutics at commercial scale.
Mark Applegate
1987 HERTZ FELLOW
MAKING HISTORY
EDUCATION
Graduate Studies
Massachusetts Institute of Technology
Chemical Engineering
Graduate Thesis
Development and Characterization of Macroporous Ceramic Matrix Bioreactors for Mammalian Cell Culture
Undergraduate Studies
University of Delaware
IMPACT STORY
Lorem ipsum dolor sit amet, consecteta aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in.ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in.
READ MORE
